Cyble Recognized by Forbes as One of America’s Best Startup Employers 2023
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cyble, the Y Combinator-backed leader in AI-powered global cyber threat intelligence, today announced…
Year: 2023
Hiring in the Healthcare Sector Soars in the Philippines with 11% Increase: foundit Insights Tracker
Overall hiring activity in the country improved by 4% on a month-on-month basis Healthcare industry…
SolarWinds Observability Now Available in Microsoft Azure Marketplace, Empowering More Customers to Manage Complex IT Environments and Accelerate Digital Transformation
Hosting on Microsoft Azure in Australia will enable more businesses in the Asia-Pacific region to…
Chevron and JERA sign MOU to explore carbon capture and storage projects in United States and Australia
HOUSTON–(BUSINESS WIRE)–Chevron New Energies (Chevron), a division of Chevron U.S.A. Inc., and JERA Co., Inc….
Ellington Residential Announces Estimated Book Value Per Share as of February 28, 2023
OLD GREENWICH, Conn.–(BUSINESS WIRE)–Ellington Residential Mortgage REIT (NYSE: EARN) (the “Company”) today announced its estimated…
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory Committee Hearing
Company Has Requested an Orderly Wind-down in Effort to Voluntarily Withdraw Makena® ZUG, Switzerland, March…
Sensei Biotherapeutics Adopts Stockholder Rights Agreement
BOSTON, March 07, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Cytek® Biosciences Introduces New 20-Color AML Panel
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD…
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock
IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global…
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
Montrouge, France, March 7, 2023 DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical…
Cidara Therapeutics Presents Preclinical Data on CD73-Targeting Drug-Fc Conjugate at the 2023 ESMO Targeted Anticancer Therapies Congress
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results
FORT WORTH, Texas, March 07, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the…
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
DEER PARK, Ill., March 07, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an…
Revolution Medicines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Underwriters’ full exercise of option brings gross proceeds to $345.0 million REDWOOD CITY, Calif., March…
BioSyent Announces Launch of New FeraMAX® Pd Maintenance 45
FeraMAX Pd Maintenance 45 FeraMAX Pd Maintenance 45 MISSISSAUGA, Ontario, March 07, 2023 (GLOBE NEWSWIRE)…
Fresh Tracks Therapeutics Announces Positive Topline Results from Single and Multiple Ascending Dose Parts of Phase 1 Study of Oral DYRK1A Inhibitor FRTX-02
FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the…
Cidara Therapeutics Announces Closing of Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares in Public Offering of Common Stock
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Business Update on Key 2023 Objectives
Pivotal study for AQST-109 (epinephrine sublingual film) on track to start in third quarter 2023…